Going global, Takeda opens up 165,000-square-foot R&D facility in San Diego
Months after consummating its hefty $62 billion deal to buy Ireland’s Shire, Japanese drugmaker Takeda is strengthening its roots in the United States and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.